9 Best Rising Penny Stocks to Buy According to Wall Street Analysts
In this article, we will look at the 9 Best Rising Penny Stocks to Buy According to Wall Street Analysts.
Ironwood Pharmaceuticals Inc (IRWD)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Armistice Capital Steven Boyd | 13,932,000 | $58,653,720 | -8% | 0.72% |
| 2. | Sarissa Capital Management Alex Denner | 9,188,635 | $38,684,153 | 21.75% | |
| 3. | Renaissance Technologies Jim Simons | 7,993,226 | $33,651,481 | -1% | 0.05% |
| 4. | AQR Capital Management Cliff Asness | 6,465,921 | $27,221,528 | -15% | 0.01% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 4,290,093 | $18,061,293 | -6% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.70 | 6,920 | $60,204.00 | 121,028 | 2024-03-06 | Filing | |
| $9.38 | 10,684 | $100,215.92 | 301,733 | 2024-03-04 | Filing | |
| $8.32 | 36,072 | $300,119.04 | 188,730 | 2023-09-15 | Filing | |
| $10.54 | 75,000 | $790,500.00 | 16,390,000 | 2021-03-10 | Filing | |
| $10.30 | 150,000 | $1,545,000.00 | 16,315,000 | 2021-03-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.52 | 127,890 | $578,062.80 | 313,680 | 2026-07-07 | Filing | |
| $3.73 | 21,571 | $80,459.83 | 250,749 | 2026-06-16 | Filing | |
| $3.31 | 5,800 | $19,198.00 | 9,188,635 | 2026-03-17 | Filing | |
| $3.05 | 6,725,000 | $20,511,250.00 | 9,194,435 | 2026-03-17 | Filing | |
| $3.66 | 19,053 | $69,733.98 | 363,886 | 2026-02-24 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 17,788,557 | $74,889,826 | 0% | |
| 2. | 8,809,601 | $37,088,420 | 0% | |
| 3. | 8,683,803 | $36,558,810 | 0% | |
| 4. | 6,608,508 | $27,821,819 | 0% | |
| 5. | 5,513,355 | $23,211,225 | 0% |
News See All
Is Ironwood Pharmaceuticals, Inc. (IRWD) Strengthening Its Growth Outlook With Expanded Pediatric Approval for Linzess?
We recently compiled a list of the 11 Most Undervalued Pharma Stocks to Invest In. Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) is one of the most undervalued stocks to invest in.
11 Most Undervalued Pharma Stocks to Invest In
In this article, we will be taking a look at the 11 Most Undervalued Pharma Stocks to Invest In.
Is Ironwood Pharmaceuticals, Inc. (IRWD) a Comeback Pharma Stock After Major Earnings Improvement?
We recently compiled a list of the 8 Best Small Cap Pharma Stocks to Buy Right Now. Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) is among the best small cap pharma stocks.
8 Best Small Cap Pharma Stocks to Buy Right Now
In this article, we will be taking a look at the 8 Best Small Cap Pharma Stocks to Buy Right Now.
7 Best Small-Cap Drug Manufacturing Stocks to Buy According to Hedge Funds
In this article, we will take a look at some of the small-cap drug manufacturing stocks that are highly favored by hedge funds.
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q4 2025 Earnings Call Transcript
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q4 2025 Earnings Call Transcript February 25, 2026Ironwood Pharmaceuticals, Inc. misses on earnings expectations.
Craig-Hallum Bullish on Ironwood Pharmaceuticals (IRWD), Keeps Buy Rating
Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) is one of the cheap hot stocks to invest in right now.
11 Cheap Hot Stocks to Invest In Right Now
On January 23, Ryan Detrick, Carson Group chief market strategist, appeared on CNBC's 'Squawk Box' to discuss the latest market trends and the outlook for 2026.
Ironwood (IRWD) Skyrockets 23% as Govt Price for Linzess Falls Within Expectations
We recently published 10 Small Stocks with Mighty Gains. Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) is one of the top-performing stocks on Wednesday.
Hedge Fund Resource Center